Compare ARCT & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | ZKH |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | China |
| Employees | N/A | 3262 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 587.4M |
| IPO Year | N/A | 2023 |
| Metric | ARCT | ZKH |
|---|---|---|
| Price | $6.50 | $3.62 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $38.67 | N/A |
| AVG Volume (30 Days) | ★ 720.2K | 245.2K |
| Earning Date | 11-10-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $97,601,000.00 | ★ $1,236,195,501.00 |
| Revenue This Year | N/A | $2.44 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $2.50 |
| 52 Week High | $24.17 | $3.90 |
| Indicator | ARCT | ZKH |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | 73.24 |
| Support Level | $6.34 | $3.16 |
| Resistance Level | $6.75 | $3.31 |
| Average True Range (ATR) | 0.39 | 0.14 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 11.28 | 97.20 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.